Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-22-017394

Chief Scientific Officer sold 4,517 shares at $12.01 ($54,249)

  • Chief Scientific Officer acquired 247,117 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2022-03-04 Grant or award +247,117 316,477 D: show line 1 in the form
ROBINS HARLAN S Chief Scientific Officer 2022-03-07 Sale −4,517 $12.01 $54,249 311,960 D: show line 2 in the form
Open-market sales · 4,517 sh · avg $12.01 · $54,249

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2022-03-04 Grant or award · Stock Option (Right to Buy) +617,792 617,792 D: show line 3 in the form
Loading xslF345X03/doc4.xml…